| Michael J Gillogley, MD | |
|
6501 Coyle Ave, Carmichael, CA 95608-0306 | |
| (330) 493-4443 | |
| (330) 493-8677 |
| Full Name | Michael J Gillogley |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 6501 Coyle Ave, Carmichael, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477567634 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G53031 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.
Breast cancer statistics published this week indicate a continuing upward trend for rates of breast cancer among African American women in the United States. The incidence of breast cancer in this population of women who have historically had low rates of breast cancer is now approaching that seen among white women.
Unraveling the molecular basis of life is an age-old quest of humanity. A breakthrough towards this goal was reported in a pair of studies published Feb. 3 in the scientific journal Nature, detailing a new method developed to determine structures of biomolecules based on diffraction from protein nanocrystals that are so small that they are not even visible under the microscope.
Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.
Researchers from the University of Liverpool have identified a specific gene that plays a key role in an inherited eye disorder.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Gillogley, MD 4535 Dressler Rd Nw, Canton, OH 44718-2545 Ph: (330) 493-4443 | Michael J Gillogley, MD 6501 Coyle Ave, Carmichael, CA 95608-0306 Ph: (330) 493-4443 |
News Archive
Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.
Breast cancer statistics published this week indicate a continuing upward trend for rates of breast cancer among African American women in the United States. The incidence of breast cancer in this population of women who have historically had low rates of breast cancer is now approaching that seen among white women.
Unraveling the molecular basis of life is an age-old quest of humanity. A breakthrough towards this goal was reported in a pair of studies published Feb. 3 in the scientific journal Nature, detailing a new method developed to determine structures of biomolecules based on diffraction from protein nanocrystals that are so small that they are not even visible under the microscope.
Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.
Researchers from the University of Liverpool have identified a specific gene that plays a key role in an inherited eye disorder.
› Verified 8 days ago
Lara Zibners, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3620 Kiekebusch Ct, Carmichael, CA 95608 Phone: 916-944-2501 | |
Dr. Dean Kim, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4156 Manzanita Ave, Suite 100, Carmichael, CA 95608 Phone: 916-483-5400 Fax: 916-483-1937 | |
John Wood, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 330-493-4443 | |
Andrew Lawrence Griffin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-864-5550 | |
Benjamin David Jones, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-537-5000 | |
Philip Nibley, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-864-5753 | |
James Goldberg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 330-493-4443 |